Dsm-265

CAS No.

1282041-94-4

MDL No.

MFCD28502125

C₁₄H₁₂F₇N₅S

415.33

InChI Key

OIZSVTOIBNSVOS-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
5 mg	99%	$147	In Stock
10 mg	99%	$197	In Stock
25 mg	99%	$269	In Stock
50 mg	99%	$437	In Stock
100 mg	99%	$783	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

5 mg

99%

$147

In Stock

10 mg

99%

$197

In Stock

25 mg

99%

$269

In Stock

50 mg

99%

$437

In Stock

100 mg

99%

$783

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1282041-94-4
Product Name	Dsm-265

Associated Conditions

Plasmodium vivax malaria·malaria·Plasmodium falciparum malaria

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

Dsm-265

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria.

Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study.

DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.

Documentation